Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors

Gene

Volumn 577, Issue 2, 2016, Pages 221-226

  Mirzadeh Azad, F ^a   Naeli, P ^a   Malakootian, M ^b   Baradaran, A ^c   Tavallaei, M ^d   Ghanei, M ^d   Mowla, S J ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biomarkers; Development related miRNAs; Lung cancer; MiR 134; MiR 187; Tumor marker

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 134; MICRORNA 187; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN134 MICRORNA, HUMAN; MIRN187 MICRORNA, HUMAN;

A549 CELL LINE; ARTICLE; CANCER GRADING; CANCER MORTALITY; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; ADENOCARCINOMA; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; BIOMARKERS, TUMOR; CELL LINE, TUMOR; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS;

EID: 84952862176     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.11.040     Document Type: Article

References (43)

1. Aqeilan R.I., Pekarsky Y., Herrero J.J., Palamarchuk A., Letofsky J., Druck T., Trapasso F., Han S.Y., Melino G., Huebner K., et al. Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(13):4401-4406.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
3. Bhaskaran M., Wang Y., Zhang H., Weng T., Baviskar P., Guo Y., Gou D., Liu L. MicroRNA-127 modulates fetal lung development. Physiol. Genomics 2009, 37(3):268-278.
4. Bonner A.E., Lemon W.J., Devereux T.R., Lubet R.A., You M. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas. Oncogene 2004, 23(5):1166-1176.
5. Brambilla C., Fievet F., Jeanmart M., de Fraipont F., Lantuejoul S., Frappat V., Ferretti G., Brichon P.Y., Moro-Sibilot D. Early detection of lung cancer: role of biomarkers. Eur. Respir. J. Suppl. 2003, 39:36s-44s.
6. Brennecke J., Hipfner D.R., Stark A., Russell R.B., Cohen S.M. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 2003, 113(1):25-36.
7. Chao A., Lin C.Y., Lee Y.S., Tsai C.L., Wei P.C., Hsueh S., Wu T.I., Tsai C.N., Wang C.J., Chao A.S., et al. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Oncogene 2012, 31(6):764-775.
8. Chen C., Shen Y., Qu Q.X., Chen X.Q., Zhang X.G., Huang J.A. Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response. Exp. Cell Res. 2013, 319(1):96-102.
9. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10(10):704-714.
10. Ettinger D.S., Akerley W., Borghaei H., Chang A.C., Cheney R.T., Chirieac L.R., D'Amico T.A., Demmy T.L., Ganti A.K.P., Govindan R., et al. Non-small cell lung cancer. J. Natl. Compr. Cancer Netw. 2012, 10(10):1236-1271.
11. Fabbri M., Iliopoulos D., Trapasso F., Aqeilan R.I., Cimmino A., Zanesi N., Yendamuri S., Han S.Y., Amadori D., Huebner K., et al. WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(43):15611-15616.
12. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19(1):92-105.
13. Gao J., Wang W.Y., Mao Y.W., Graff J., Guan J.S., Pan L., Mak G., Kim D., Su S.C., Tsai L.H. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010, 466(7310):1105-1109.
14. Gaughwin P., Ciesla M., Yang H., Lim B., Brundin P. Stage-specific modulation of cortical neuronal development by Mmu-miR-134. Cereb. Cortex 2011, 21(8):1857-1869.
15. Harris K.S., Zhang Z., McManus M.T., Harfe B.D., Sun X. Dicer function is essential for lung epithelium morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(7):2208-2213.
16. Hartwell L., Mankoff D., Paulovich A., Ramsey S., Swisher E. Cancer biomarkers: a systems approach. Nat. Biotechnol. 2006, 24(8):905-908.
17. Herbst R.S., Heymach J.V., Lippman S.M. Lung cancer. N. Engl. J. Med. 2008, 359(13):1367-1380.
18. Hoffman P.C., Mauer A.M., Vokes E.E. Lung cancer. Lancet 2000, 355(9202):479-485.
19. Hofmeyer K.A., Ray A., Zang X. The contrasting role of B7-H3. Proc. Natl. Acad. Sci. 2008, 105(30):10277-10278.
20. Hosseini M., Naghan P.A., Karimi S., SeyedAlinaghi S., Bahadori M., Khodadad K., Mohammadi F., Kaynama K., Masjedi M.R. Environmental risk factors for lung cancer in Iran: a case-control study. Int. J. Epidemiol. 2009, 38(4):989-996.
21. Iliopoulos D., Guler G., Han S.Y., Johnston D., Druck T., McCorkell K.A., Palazzo J., McCue P.A., Baffa R., Huebner K. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene 2005, 24(9):1625-1633.
22. Ketting R.F. microRNA biogenesis and function: an overview. Adv. Exp. Med. Biol. 2011, 700:1-14.
23. Kitamura K., Seike M., Okano T., Matsuda K., Miyanaga A., Mizutani H., Noro R., Minegishi Y., Kubota K., Gemma A. MiR-134/487b/655 cluster regulates TGF-beta-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells. Mol. Cancer Ther. 2014, 13(2):444-453.
24. Lin P.Y., Yu S.L., Yang P.C. MicroRNA in lung cancer. Br. J. Cancer 2010, 103(8):1144-1148.
25. Liu H., Kohane I. Tissue and process specific microrna - mrna co-expression in mammalian development and malignancy. PLoS ONE 2009, 4(5).
26. Liu X., Sempere L.F., Ouyang H., Memoli V.A., Andrew A.S., Luo Y., Demidenko E., Korc M., Shi W., Preis M., et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J. Clin. Invest. 2010, 120(4):1298-1309.
27. Liu C.J., Shen W.G., Peng S.Y., Cheng H.W., Kao S.Y., Lin S.C., Chang K.W. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene. Int. J. Cancer 2014, 134(4):811-821.
28. Mendell J. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133(2):217-222.
29. Nygren M.K., Tekle C., Ingebrigtsen V.A., Makela R., Krohn M., Aure M.R., Nunes-Xavier C.E., Perala M., Tramm T., Alsner J., et al. Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c. Br. J. Cancer 2014, 110(8):2072-2080.
30. Poitz D.M., Stolzel F., Arabanian L., Friedrichs J., Docheva D., Schieker M., Fierro F.A., Platzbecker U., Ordemann R., Werner C., et al. MiR-134-mediated beta1 integrin expression and function in mesenchymal stem cells. Biochim. Biophys. Acta 2013, 1833(12):3396-3404.
31. Prunier C., Howe P.H. Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT). J. Biol. Chem. 2005, 280(17):17540-17548.
32. Shenouda S.K., Alahari S.K. MicroRNA function in cancer: oncogene or a tumor suppressor?. Cancer Metastasis Rev. 2009, 28(3-4):369-378.
33. Tay Y., Zhang J., Thomson A.M., Lim B., Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455(7216):1124-1128.
34. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7(2):131-142.
35. Tolkacheva T., Boddapati M., Sanfiz A., Tsuchida K., Kimmelman A.C., Chan A.M. Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383. Cancer Res. 2001, 61(13):4985-4989.
36. Valiente M., Andres-Pons A., Gomar B., Torres J., Gil A., Tapparel C., Antonarakis S.E., Pulido R. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J. Biol. Chem. 2005, 280(32):28936-28943.
37. Whitsett J., Haitchi H., Maeda Y. Intersections between pulmonary development and disease. Am. J. Respir. Crit. Care Med. 2011, 184(4):401-406.
38. Williams A.E., Moschos S.A., Perry M.M., Barnes P.J., Lindsay M.A. Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev. Dyn. 2007, 236(2):572-580.
39. Yendamuri S., Kuroki T., Trapasso F., Henry A.C., Dumon K.R., Huebner K., Williams N.N., Kaiser L.R., Croce C.M. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res. 2003, 63(4):878-881.
40. Zhang X., Wang H., Zhang S., Song J., Zhang Y., Wei X., Feng Z. MiR-134 functions as a regulator of cell proliferation, apoptosis, and migration involving lung septation. In Vitro Cell. Dev. Biol. Anim. 2012, 48(2):131-136.
41. Zhang Y., Yang D., Weng L., Wang L. Early lung cancer diagnosis by biosensors. Int. J. Mol. Sci. 2013, 14(8):15479-15509.
42. Zhang W., Wang J., Wang Y., Dong F., Zhu M., Wan W., Li H., Wu F., Yan X., Ke X. B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells. Onco. Targets Ther. 2015, 8:1721-1733.
43. Zhao J., Lei T., Xu C., Li H., Ma W., Yang Y., Fan S., Liu Y. MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3. Biochem. Biophys. Res. Commun. 2013, 438(2):439-444.